SYNCHRONOUS CLEAR CELL RENAL CELL CARCINOMA AND TUBULOCYSTIC RENAL CELL CARCINOMA
Journal Title: Era's Journal of Medical Research - Year 2016, Vol 3, Issue 2
Abstract
Tubulocystic renal cell carcinoma (TCRCC) is a recently described rare subtype of RCC. To best of our knowledge less than 70 cases have been reported till date. The concurrent papillary RCC (PRCC) and TCRCC has been documented in literature, but the co-occurrence of clear cell RCC (CCRCC) and TCRCC is very rare. We are describing a rare case of incidentally detected TCRCC occurring with CCRCC in a 45 years old male who presented with high grade fever with chills and rigors. Grossly, there were two distinct tumors in the total nephrectomy specimen. The larger tumor displayed the histopathological features of CCRCC and the smaller tumor revealed the features of TCRCC.treatment in the present case.
Authors and Affiliations
Manoj Jain, Shruti Agrawal, Sushila Jaiswal, Bharti Ramnani Ramnani, Anil Mandhani Mandhani
PRACTICAL PATHOLOGY(WITH VIVA VOCE) By: Tejinder Singh & Uma Chaturvedi
Practical teaching in Pathology at UG level includes exercises of Clinical Pathology like urine examination , and Hematology which includes, Hemoglobin, PCV and ESR estimations. Preparation of a blood smear and their sta...
A RETROSPECTIVE COMPARATIVE STUDY OF OUTCOMES IN PATIENTS OF PERFORATED PEPTIC ULCER APPLIED WITH CELLAN-JONES REPAIR VERSUS GRAHAM'S PATCH
Perforated Peptic ulcer is a complication of peptic ulcer disease (PUD) and is a surgical emergency with high morbidity and mortality. This study was undertaken to compare the outcome in patients treated with Cellan-Jone...
CANCER STEM CELL IN GLIOBLASTOMA MULTIFORME
Glioblastoma multiforme (GBM) is an aggressive tumor that typically exhibits treatment failure with high mortality rates, is associated with the presence of cancer stem cells (CSCs) within the tumor. CSCs possess the abi...
METHOTREXATE INDUCED STEVENS JOHNSON SYNDROME: A RARE CASE REPORT
Methotrexate (MTX) is a folic acid antagonist with cytotoxic and immunosuppressant activity andwith potent antirheumatic action. It is commonly a first choice Disease modifying antirheumatic drug (DMARD). There were some...
A LOOK AT THE DIFFICULTIES IN THE DIAGNOSIS, MANAGEMENT AND TREATMENT OF PATIENTS WITH SCHIZOAFFECTIVE DISORDER
In this case we discuss patient RJ (not real initials) a young African American Muslim male who presents near the start of his illness and the struggles he is facing of accepting his diagnosis and treatment plan. This ca...